House GOP Takes Pharma’s Side In Debate Over Aduhelm

By Gabrielle Wanneh / February 10, 2022 at 11:23 AM

House Republicans are taking pharma’s side in the debate over Medicare coverage of the Alzheimer’s drug Aduhelm, and they’ve added a new complaint: that CMS’ proposed policy would exclude people with Down Syndrome.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.